Impingement Syndrome Market to Grow with a CAGR of 7.11% through 2028
Rising prevalence of impingement syndrome and increasing
healthcare expenditure are factors driving the global Impingement Syndrome market in the forecast
period 2024-2028.
According to TechSci Research report, “Impingement
Syndrome Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2028”, the Global Impingement Syndrome Market
stood at USD 7.35 billion in 2022 and is anticipated to grow with a CAGR of 7.11%
in the forecast period, 2024-2028. Impingement
syndrome, also known as shoulder impingement, is a common orthopedic condition
that affects millions of individuals worldwide. This condition occurs when the
tendons of the rotator cuff muscle in the shoulder become irritated and
inflamed as they pass through a narrow space known as the subacromial space. As
the global population ages and the demand for effective healthcare solutions
continues to rise, the market for impingement syndrome treatment is
experiencing significant growth. One of the primary drivers of the impingement
syndrome market is the increasing prevalence of this condition. Lifestyle
factors such as sedentary work, poor posture, and repetitive overhead
activities have contributed to a growing number of individuals experiencing
shoulder pain and impingement syndrome. Additionally, the aging population is
more susceptible to orthopedic conditions, including impingement syndrome. As
the global population continues to age, the demand for effective treatments for
this condition is expected to rise, driving market growth.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Impingement Syndrome Market.”
Advancements in medical technology have
significantly improved the diagnosis of impingement syndrome. More accurate and
non-invasive diagnostic tools, such as magnetic resonance imaging (MRI) and
ultrasound, are now available to healthcare professionals. These tools enable
early and precise diagnosis, allowing for timely intervention and treatment
planning. The adoption of advanced diagnostic technologies is boosting the
impingement syndrome market by facilitating better patient outcomes and
reducing the need for invasive procedures.
The global impingement syndrome market
has witnessed the development of innovative treatment options. While
conservative approaches like physical therapy, rest, and anti-inflammatory
medications remain important, surgical interventions have also evolved. Arthroscopic
procedures, which involve small incisions and minimally invasive techniques,
have gained popularity in treating impingement syndrome. These procedures offer
quicker recovery times and lower postoperative pain, attracting more patients
to opt for surgical solutions. The availability of innovative treatment options
is driving market growth by providing patients with a range of choices. The
global healthcare expenditure has been on the rise, driven by factors such as
population growth, increasing awareness of healthcare needs, and advancements
in medical technology. As a result, individuals are more willing to seek
medical care for conditions like impingement syndrome. Healthcare providers are
investing in better facilities, equipment, and specialized orthopedic services
to meet this demand. The increase in healthcare expenditure has a direct impact
on the growth of the impingement syndrome market by improving access to
diagnosis and treatment.
The Global Impingement Syndrome Market is segmented into
type of musculoskeletal disorder, diagnosis and imaging techniques, treatment
modalities, end user and company.
Based on end user, the Hospitals & Clinics segment has
emerged as the predominant market leader. Many hospitals are affiliated with research
institutions and have access to the latest advancements in orthopedic medicine.
This enables them to offer cutting-edge treatments and participate in clinical
trials aimed at improving impingement syndrome management. After surgery or
as part of non-surgical treatment plans, rehabilitation services play a
critical role in restoring mobility and function. Hospitals and clinics have
dedicated rehabilitation facilities and expert staff to guide patients through
their recovery.
Based on region, North America segment is expected to
grow during the forecast period. The United States and Canada have a
highly skilled and specialized healthcare workforce, including orthopedic
surgeons, physical therapists, and rehabilitation specialists. These
professionals undergo rigorous training and education to provide the best possible
care for patients with impingement syndrome. Their expertise, combined with
access to advanced technology, ensures that patients receive the highest
quality care and rehabilitation services. The prevalence of impingement syndrome is on the rise
globally, driven by factors such as an aging population and increased
participation in sports and physical activities. North America is no exception
to this trend, and its healthcare system is well-equipped to meet the growing
demand for impingement syndrome diagnosis and treatment. As the region's
population continues to age and engage in sports, the demand for orthopedic
care is expected to increase, further solidifying North America's dominance in
the global market.
The Asia Pacific region is experiencing rapid market
growth. The region hosts numerous prominent pharmaceutical and medical device
firms that make significant investments in research and development (R&D).
These enterprises consistently work towards creating innovative drugs,
treatments, and medical equipment to enhance the diagnosis and treatment of
impingement syndrome.
Major companies operating in Global Impingement
Syndrome Market are:
- Bioventus LLC
- Orthofix Medical Inc.
- Breg, Inc.
- CONMED Corporation
- Ossur hf.
- DJO Global, Inc.
- Arthrex, Inc.
- Wright Medical Group N.V.
- Globus Medical, Inc.
- NuVasive, Inc.
- Smith & Nephew plc
- Stryker Corporation
- Medtronic plc
- Zimmer Biomet Holdings, Inc.
- Johnson & Johnson
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The global impingement syndrome market is
experiencing significant growth due to several key market drivers. The rising
prevalence of the condition, technological advancements in diagnostic tools,
innovative treatment options, increasing healthcare expenditure, and patient
education and awareness efforts are all contributing to the expansion of this
market.,” said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based management consulting firm.
“Impingement Syndrome Market By Type of Musculoskeletal
Disorder (Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Back and Neck
Pain, Shoulder Impingement Syndrome, Knee Pain and Disorders, Hip Pain and
Disorders, Trauma and Fracture, Sports Injuries, Others), By Diagnosis and
Imaging Techniques (X-ray, Magnetic Resonance Imaging (MRI), Computed
Tomography (CT) Scan, Ultrasound, Arthroscopy, Others), By Treatment
Modalities(Medications(Non-Steroidal Anti-Inflammatory Drugs (NSAIDs),
Analgesics, Steroids, Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Physical
Therapy and Rehabilitation, Corticosteroid Injections), Surgical
Interventions(Arthroscopic Surgery, Joint Replacement Surgery, Other Orthopedic
Surgeries),By End User (Hospitals & Clinics, Ambulatory Care Centers,
Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Impingement Syndrome Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Impingement Syndrome Market.
Contact
Mr. Ken
Mathews
708 Third
Avenue,
Manhattan, NY,
New York –
10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com